BioSpace News Archive

Aytu BioPharma, Inc. today announced that management will participate in a panel discussion titled, Managing Clinical Trials for Rare Diseases During & After COVID-19, during the Cantor Fitzgerald Virtual Rare Orphan Disease Summit on Tuesday, March 29, 2022 at 11:00 a.m. ET.

Edesa Biotech, Inc. today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of 2,739,727 of the Company’s common shares.

Pharvaris (Nasdaq: PHVS), has published pharmacological data for the novel small molecule bradykinin (BK) B2-receptor antagonist PHA121 (PHA-022121) and its active metabolite PHA-022484, in a recent open-access article in International Immunopharmacology and will be published in the April 2022 issue of the journal.

Aldeyra Therapeutics, Inc. today announced that it will host a Research & Development Day from 10:00 a.m. to 12:30 p.m. ET on Tuesday, March 29, 2022 in New York City.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has advanced VX-147 into pivotal development for people living with proteinuric kidney disease mediated by two mutations in the APOL1 gene (AMKD), which affects approximately 100,000 people in the U.S. and Europe.

Waters Corporation introduced new software and analytical columns to aid biomolecule drug discovery and development.

Peptilogics will present three papers at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting in Chicago March 24.

ENDRA Life Sciences Inc. today announced that the company will report financial results for the fourth quarter of 2021 on Wednesday, March 30, 2022 after the close of trading on the U.S. financial markets.

AM-Pharma’s purpose is to save and improve the lives of patients confronted with severe medical conditions.

Spago Nanomedical AB will present a poster summarizing its platform technology for precision imaging and therapy at the scientific conference ACS Spring 2022, which is held digitally on March 20-24.